Olfactory Neuroblastoma, also known as esthesioneuroblastoma, is related to nasal cavity olfactory neuroblastoma and sinonasal undifferentiated carcinoma. An important gene associated with Olfactory Neuroblastoma is SYP (Synaptophysin), and among its related pathways/superpathways are Signal Transduction and Pleural mesothelioma. The drugs Cetuximab and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include bone and endothelial, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Reduced mammosphere formation